Arizona Tribune - Boulevard

Results from Phase 1 Multiple-Dose Study of PT00114

Findings support advancement into Phase 2 to explore a first-in-class pathway aimed at stress-related neuropsychiatric conditions

SETO Holdings,Inc Acquires CapCity Beverage, LLC to Strengthen U.S. Importation, Distribution Infrastructure, and Brand Acceleration

The acquisition solidifies SETO's control over U.S. importation, compliance, and national distribution-positioning the company to scale its brand portfolio with greater speed, efficiency, and market access.

Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025

100% of patients in Cohorts 1-3 remain free of cytokine release syndromeCRIS-7-derived CD3 design underpins a controlled T-cell response, supporting the differentiated safety profile, combinability with standard of care

Ensysce Biosciences Achieves Major Milestone with Initiation of Enrollment in Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid

~ Engineered to Deliver Potent Pain Relief with Unique, Built-In, Abuse Protection ~

BioNxt Advances "Melt in Your Mouth" Cladribine Formulation to Improve Treatment for MS Patients with Dysphagia

VANCOUVER, BC / ACCESS Newswire / December 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is advancing the development of a next-generation "Melt in Your Mouth" cladribine formulation, built on the Company's proprietary oral dissolvable film (ODF) drug-delivery system. The technology is designed for rapid, sublingual (under-the-tongue) absorption of medication and aims to improve treatment access and comfort for people living with multiple sclerosis (MS). BioNxt's lead program, BNT23001, is being developed as a swallow-free alternative to cladribine tablets, which generated USD 1.28 billion in global sales in 2024.

10 reported hurt after big Japan quake, warning of more tremors

At least 10 people were reported injured on Tuesday but there appeared to be no major damage after a big quake rocked northern Japan and triggered tsunami waves up to 70 centimetres (28 inches) high.

Powerful 7.6 quake strikes off Japan, tsunami warning lifted

A major earthquake rocked Japan's northern coast on Monday, with the country's meteorological agency recording several tsunami waves and local media reporting injuries.

100 abducted Nigerian children handed over to state officials

Around 100 schoolchildren kidnapped from a Catholic school in Nigeria last month were handed over to state officials Monday, AFP reporters saw.

Court will give decision in Sala compensation hearing on March 30

A commercial court examining the long-running dispute between Cardiff City and French club Nantes over compensation for the death of Emiliano Sala in a plane crash said Monday it would give its decision on March 30 next year.

Sala compensation hearing opens in Cardiff's dispute with Nantes

A court hearing about the long-running dispute between Cardiff City and French club Nantes over compensation for the death of Emiliano Sala in a plane crash six years ago opened on Monday.

Ex-footballer Barton handed suspended sentence for offensive posts

Former Premier League footballer Joey Barton was spared jail on Monday after being given a suspended sentence for grossly offensive social media posts concerning British broadcaster Jeremy Vine and television pundits Lucy Ward and Eni Aluko.

Indonesia suffers food, medical shortages as Asia flood tolls rise

Regions hit by floods that killed hundreds in Indonesia were suffering from food and medical shortages, authorities said, as elephants pitched in on Monday to help clear up debris.

Hardships mount in Indonesia and Sri Lanka as flood tolls rise

Officials in flood-hit parts of Indonesia reported shortages of food, shelter, and medicine as the death toll reached 950 Monday following weeks of heavy rain.

Bausch Health Announces Early Exchange Offer Results for Exchange Offers

LAVAL, QC / ACCESS Newswire / December 8, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") announced today the results to date of its previously announced offers to exchange the Company's outstanding 4.875% Senior Secured Notes due 2028 (the "4.875% Notes") and 11.00% Senior Secured Notes due 2028 (the "11.00% Notes" and together with the 4.875% Notes, the "Existing Senior Secured Notes") for up to $1.6 billion aggregate principal amount (the "Maximum Notes Amount") of new 10.00% Senior Secured Notes due 2032 (the "New Notes" and, such offers, the "Offers") to be issued by the Company's indirect wholly-owned subsidiary 1261229 B.C. Ltd. (together with the Company, the "Offerors"), in each case, pursuant to the terms described in a confidential exchange offer memorandum dated November 24, 2025 (the "Exchange Offer Memorandum"). All terms and conditions of the Offers remain unchanged as set forth in the Exchange Offer Memorandum.

For 1 Penny Today, Lock in 50% Off Any Membership for 1 Year

Club Car Wash Offers Its Best Deal Ever Before Opening in Colorado Springs

Get Club Car Wash's Best Deal Ever Before Its Grand Opening in San Antonio

Lock-In 50% Off Any Membership for a Year for 1 Penny Today

Jaguar Health Reports Approval of All Proposals at December 2025 Special Meeting of Stockholders

Jaguar CEO Lisa Conte presenting December 10 from 3:25pm - 3:35pm Eastern at the Emerging Growth Conference to provide updates on near-term catalysts; Click here to registerInitial results of ongoing investigator-initiated proof-of-concept trial demonstrate crofelemer can potentially extend the lives of infants born with intestinal failure due to microvillus inclusion disease (MVID), reducing the volume of the total parenteral support (PS) necessary for them to survive, though with associated toxicity; Groundbreaking PS reduction of up to 37%; No approved treatments exist for MVIDCompany completed meeting with FDA October 2, 2025 for advice on advancing its ongoing placebo-controlled trial of crofelemer in support of possible expedited approval pathway for crofelemer for treatment of MVID

Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025

HACKENSACK, NJ / ACCESS Newswire / December 8, 2025 / Champions Oncology, Inc. (CSBR), a leading translational oncology research organization, will report its financial and operational results for the second quarter ended October 31, 2025, on Monday, December 15, 2025, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EST (1:30 P.M. PST). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 691139. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 53331, or by accessing the investors section of the company's website within 72 hours.

Anatomy Warehouse Expands Hands-On Partners Program with Faculty Edition for Educators

CHICAGO, IL / ACCESS Newswire / December 8, 2025 / Anatomy Warehouse, a leading distributor of anatomical models and simulation training tools, today announces the launch of Hands-On Partners: Faculty Edition, a new educator-focused track within its growing affiliate network.

Medical Care Technologies (OTC Pink:MDCE) Positions Itself in the Multi-Billion Dollar AI Dermatology Market With Google-Backed Melanoma Detection Technology

MESA, ARIZONA / ACCESS Newswire / December 8, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is thrilled to announce a major technology advancement in the development of its soon-to-launch AI wound and skin monitoring platform. The Company has strategically aligned with Derm Foundation, a Google-backed pretrained dermatology imaging model, enabling the app to rapidly evolve into one of the most accessible early-warning tools for melanoma, infection risks, and chronic wound deterioration directly from a smartphone.

Who Does the Best Liposuction in Las Vegas?

The Best Liposuction in Las Vegas is by Dr. Ahmed

CASI Pharmaceuticals Announces Results from CID-103 Immune Thrombocytopenia Study at the 67th American Society of Hematology (ASH) Annual Meeting

SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 8, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company developing CID-103, a potentially best-in-class, anti-CD38 monoclonal antibody, for patients with organ transplant rejection and autoimmune diseases, today announced data presented from its Phase 1 open-label study of CID-103 in adult patients with immune thrombocytopenia (ITP) at the 67th American Society of Hematology Annual Meeting and Exposition on December 7, 2025, in Orlando, Florida.

Armanino Foods Announces Fourth Quarter 2025 Dividend

Quarterly Cash Dividend of $0.05 per Share to be Paid to Shareholders of Record as of January 16, 2026

Survey Reveals Cautious Optimism in PIPE Market as Investors Eye Technology, Healthcare, and Cleantech in 2026

NEW YORK, NY / ACCESS Newswire / December 8, 2025 / DealFlow Events today released the results of its PIPE Market Trends & Sentiment Survey, conducted during the 2025 PIPEs Conference. The findings point to measured but growing optimism in the market, with a majority of respondents describing current PIPE conditions as at least "somewhat healthy" and expecting transaction activity to increase over the next year.

Wellgistics Health Announces Launch of Diabetes Drug Brenzavvy(R) to Wellgistics Pharmacy Network

Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are uninsured and underinsured and whose out-of-pocket costs exceed Brenzavvy's cash priceProprietary EinsteinRx™ artificial intelligence pharmacy platform empowers the 6,500+ pharmacies in the Wellgistics Pharmacy Network to educate patients and providers on the advantages of Brenzavvy vs. Jardiance® and other SGLT-2 inhibitorsReduced out-of-pocket costs for patients, paired with a patient-education revenue opportunity for pharmacists, are designed to support broader market access to Brenzavvy and enhance the overall care experienceLaunch establishes a new model for next-generation reformulated drugs that offer patient-specific product advantages compared with entrenched market leaders

Avant Brands Fully Repays $9.5M Secured Convertible Debenture

KELOWNA, BC / ACCESS Newswire / December 8, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, today announced the full repayment of its $9.5 million amended and restated convertible debenture (the "A&R Debenture"). The final payment was completed in November 2025, retiring in full the obligation originally issued in connection with the 2023 acquisition of 3PL Ventures Inc.

Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz

All closing requirements satisfied following announcement of a non-binding term-sheet agreement in July and signing of contract in NovemberAgreement includes approximately US$ 350 m in cash for Just - Evotec Biologics manufacturing site in Toulouse and upfront technology license fees to Evotec's continuous manufacturing platformIn addition, Evotec eligible for license fees, and development revenues including success-based milestones adding up to more than US$ 300 m over the coming years,replacing existing contractual commitmentsTransaction covering royalties on a portfolio ofup to ten biosimilars in technical and early development targetingmore than US$ 90 bn of originator net salesSale immediately earnings accretive, improving Evotec's short, mid and long-term revenue mix, profit margins, and capital efficiency

100 kidnapped Nigerian schoolchildren released: UN source, presidency

Nigerian authorities have secured the release of 100 kidnapped schoolchildren taken by gunmen from a Catholic school last month, a UN source and local media said Sunday, though the fate of the 165 students and staff thought to remain in captivity remains unclear.

Renowned British photographer Martin Parr dies aged 73

Celebrated British documentary photographer Martin Parr has died at his home in the western English city Bristol, his foundation announced on Sunday. He was 73.

India nightclub fire kills 25 in Goa

A fire that ripped through an Indian nightclub in the popular tourist resort region of Goa killed 25 people, the state's chief minister said Sunday.

India nightclub fire kills 23 in Goa

A fire at a nightclub in the west Indian state of Goa has killed at least 23 people, Chief Minister Pramod Sawant and other officials said early Sunday.

MSP Recovery, Inc. Announces Conclusion of SEC Investigation: No Intention to Recommend Enforcement Action Against the Company, its CEO, John H. Ruiz, or its Officers

MIAMI, FLORIDA / ACCESS Newswire / December 7, 2025 / MSP Recovery, Inc. (NASDAQ:MSPR) (the "Company"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, announces that the staff of the U.S. Securities and Exchange Commission ("SEC") has informed the Company that it has concluded its investigation relating to MSP Recovery, Inc., and does not intend to recommend enforcement action to the Commission against the Company, its CEO, John H. Ruiz, or its officers.

RBGPF	-19.57%	69	$
BTI	-1.87%	58.85	$
GSK	1.7%	58.36	$
CMSC	0.45%	22.39	$
BP	0.02%	45.9	$
NGG	0.4%	90.32	$
CMSD	0.4%	22.59	$
AZN	0.35%	204.99	$
RIO	-1.36%	97.13	$
RELX	-1.77%	33.34	$
BCE	-0.96%	23.89	$
RYCEF	11.49%	17.23	$
VOD	0.5%	15.85	$
BCC	1.68%	80.58	$
JRI	1%	12.98	$

Arizona Tribune - Boulevard (English)

Featured

Sleepy seal diverts traffic in Australian seaside town

Exiled cartoonists give voice to Iran's silenced millions

Last news